Silvia Baldari

1.6k total citations
24 papers, 1.2k citations indexed

About

Silvia Baldari is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Silvia Baldari has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Silvia Baldari's work include Extracellular vesicles in disease (4 papers), Mesenchymal stem cell research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Silvia Baldari is often cited by papers focused on Extracellular vesicles in disease (4 papers), Mesenchymal stem cell research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Silvia Baldari collaborates with scholars based in Italy, Malaysia and United States. Silvia Baldari's co-authors include Gabriele Toietta, Giuliana Di Rocco, Michela Pozzobon, Maurizio Muraca, Martina Piccoli, Timothy A. Su, Marie C. Heffern, Christopher J. Chang, Alessia Garufi and Gabriella D’Orazi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Silvia Baldari

23 papers receiving 1.2k citations

Peers

Silvia Baldari
Seock‐Won Youn United States
Yihui Shi United States
Dian Wang China
Kevin Taylor United States
Zeng Fan China
Seock‐Won Youn United States
Silvia Baldari
Citations per year, relative to Silvia Baldari Silvia Baldari (= 1×) peers Seock‐Won Youn

Countries citing papers authored by Silvia Baldari

Since Specialization
Citations

This map shows the geographic impact of Silvia Baldari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Baldari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Baldari more than expected).

Fields of papers citing papers by Silvia Baldari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Baldari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Baldari. The network helps show where Silvia Baldari may publish in the future.

Co-authorship network of co-authors of Silvia Baldari

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Baldari. A scholar is included among the top collaborators of Silvia Baldari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Baldari. Silvia Baldari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardo, Maddalena Di, Simonetta Astigiano, Silvia Baldari, et al.. (2024). The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 49–49. 4 indexed citations
2.
Baldari, Silvia, Annalisa Antonini, Giuliana Di Rocco, & Gabriele Toietta. (2024). Expression Pattern and Prognostic Significance of Aldehyde Dehydrogenase 2 in Lung Adenocarcinoma as a Potential Predictor of Immunotherapy Efficacy. SHILAP Revista de lepidopterología. 4(1). e149–e149.
3.
Baldari, Silvia, Francesca Di Modugno, Paola Nisticò, & Gabriele Toietta. (2022). Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy. Cancers. 14(19). 4706–4706. 30 indexed citations
4.
Garufi, Alessia, Silvia Baldari, Riccardo Pettinari, et al.. (2020). A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status. Journal of Experimental & Clinical Cancer Research. 39(1). 122–122. 27 indexed citations
5.
Trivisonno, Angelo, Dania Nachira, Ivo Boškoski, et al.. (2020). Regenerative medicine approaches for the management of respiratory tract fistulas. Stem Cell Research & Therapy. 11(1). 451–451. 14 indexed citations
7.
Baldari, Silvia, Giuliana Di Rocco, & Gabriele Toietta. (2020). Current Biomedical Use of Copper Chelation Therapy. International Journal of Molecular Sciences. 21(3). 1069–1069. 144 indexed citations
8.
Baldari, Silvia, Giuliana Di Rocco, Alessandra Magenta, Mario Picozza, & Gabriele Toietta. (2019). Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation. Cells. 8(12). 1560–1560. 52 indexed citations
9.
Sarogni, Patrizia, Orazio Palumbo, Adele Servadio, et al.. (2019). Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. Journal of Experimental & Clinical Cancer Research. 38(1). 108–108. 36 indexed citations
10.
Trivisonno, Angelo, Robert W. Alexander, Silvia Baldari, et al.. (2019). Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise Review. Stem Cells Translational Medicine. 8(12). 1265–1271. 65 indexed citations
11.
Baldari, Silvia, Giuliana Di Rocco, Marie C. Heffern, et al.. (2019). Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells. Cancers. 11(5). 659–659. 178 indexed citations
12.
Rocco, Giuliana Di, Silvia Baldari, Giovambattista Pani, & Gabriele Toietta. (2018). Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells. Cellular and Molecular Life Sciences. 76(2). 231–244. 42 indexed citations
13.
Rocco, Giuliana Di, Silvia Baldari, Antonietta Gentile, Maurizio C. Capogrossi, & Gabriele Toietta. (2018). Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases. Stem Cell Research & Therapy. 9(1). 250–250. 8 indexed citations
14.
Baldari, Silvia, Giuliana Di Rocco, Martina Piccoli, et al.. (2017). Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies. International Journal of Molecular Sciences. 18(10). 2087–2087. 205 indexed citations
15.
Garufi, Alessia, Giuseppa Pistritto, Silvia Baldari, et al.. (2017). p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions. Journal of Experimental & Clinical Cancer Research. 36(1). 126–126. 30 indexed citations
16.
Rocco, Giuliana Di, Silvia Baldari, & Gabriele Toietta. (2016). Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis. Stem Cells International. 2016(1). 5029619–5029619. 108 indexed citations
17.
Baldari, Silvia, et al.. (2015). Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications. Cell Death and Disease. 6(1). e1621–e1621. 42 indexed citations
18.
Garufi, Alessia, Francesca Mancini, Valerio D’Orazi, et al.. (2015). The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells. Journal of Experimental & Clinical Cancer Research. 34(1). 87–87. 29 indexed citations
19.
D’Arcangelo, Daniela, Aymone Gurtner, Eleonora Cesareo, et al.. (2014). Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist. Oncogene. 34(19). 2493–2504. 63 indexed citations
20.
Murfuni, Ivana, Sara Nicolai, Silvia Baldari, et al.. (2012). The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene. 32(5). 610–620. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026